The Pharmacy Times® Immunization Resource Center is a comprehensive resource for clinical news and expert insights on common immunizations, such as flu, zoster, and COVID-19 vaccines.
November 20th 2024
Data from the BROADEN and PROGRESS studies were presented at the International Papillomavirus Conference 2024 in Edinburgh, UK, from November 12 to 15.
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
Pneumococcal Disease Prevention for Older Adults and the Pharmacist’s Role in an Evolving Vaccine Landscape
1.0 Credit / Immunization, Infectious Diseases
View More
Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Ac...
1.5 Credits / HIV/AIDS, Infectious Diseases
View More
The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...
2.0 Credits / Human Trafficking, Law
View More
Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies
1.0 Credit / Law, Pain Management, Opioids
View More
The Role of the Pharmacist in Influenza Prevention for At-Risk Adults: Strategies to Enhance Immunization
1.5 Credits / Infectious Disease
View More
The Essential Role of Pharmacists in Improving Influenza Vaccination Coverage: Strategies to Increase Vaccine ...
1.0 Credit / Immunization, Infectious Disease
View More
The Role of Pharmacists in Pneumococcal Prevention: Strategies to Improve Vaccine Uptake
1.0 Credit / Immunization, Infectious Disease, Pulmonology
View More
Frontline Health Care Workers Are Helping to Shape COVID-19 Vaccine Toolkit Resources
March 25th 2021Farah Towfic, PharmD, MBA, director, CEO operations at US Pharmacopeia (USP), discusses USP’s release of an updated version of its COVID-19 Vaccine Handling Toolkit in response to feedback from independent pharmacies to mass vaccination clinics.
Watch
Fauci: DSMB Challenge of New AstraZeneca COVID-19 Vaccine Data Is an ‘Unfortunate Incident’
March 23rd 2021Following a review of the latest interim data released by AstraZeneca on its US phase 3 clinical trial assessing the 2-dose AZD1222 COVID-19 vaccine, the Data and Safety Monitoring Board (DSMB) expressed concern at the inclusion of what may have been outdated data.
Read More
Phase 3 Trial of Adjuvanted COVID-19 Vaccine Candidate Commences Enrollment in the US, Canada
March 23rd 2021Phase 3 clinical testing of a plant-derived COVID-19 vaccine candidate in combination with a pandemic adjuvant commenced following approval to proceed with participant enrollment from regulatory authorities in both Canada and the United States.
Read More
First Participants Dosed in Phase 2/3 Study on Moderna’s COVID-19 Vaccine in Pediatric Population
March 22nd 2021The first participants were dosed in the phase 2/3 KidCOVE study investigating vaccine candidate mRNA-1273 against COVID-19 in children aged 6 months to less than 12 years of age.
Read More
CDC Analysis Finds Most People Receive Second COVID-19 Shot on Time
March 18th 2021Health care professionals should address potential barriers to completing the COVID-19 vaccination series, including scheduling second-dose appointments at the first-dose administration and sending reminders for second-dose visits.
Read More
Poll Shows Big Shift in High-Risk Older Adults' Attitudes Toward COVID-19 Vaccination
March 16th 2021A follow-up poll from the University of Michigan (U-M) found that 71% of people in their 50s, 60s, and 70s are now ready to get vaccinated against COVID-19 when a dose becomes available to them.
Read More
The Challenges of Coordinating COVID-19 Vaccine Distribution Across NYC’s Public Health System
March 11th 2021Danielle DiBari, the chief pharmacy officer and senior vice president of business operations for NYC Health + Hospitals, discusses some of the challenges involved in coordinating vaccine distribution across New York’s public health system.
Watch
Walgreens Announces the Successful Administration of 5 Million COVID-19 Vaccinations
March 9th 2021In a recent statement, Walgreens announced that it has administered approximately 5 million COVID-19 vaccinations at long-term care facilities, in its stores, and through its vaccination clinics.
Read More
How to Discuss the FDA’s Expedited EUA Process With Vaccine Hesitant Patients
March 9th 2021Pharmacy Times® interviewed Chad Landmon, JD, chair of intellectual property and FDA practice groups at Axinn, Veltrop & Harkrider, on how to approach discussing the FDA’s expedited EUA process for COVID-19 vaccines with patients with concerns about the process.
Watch